Table 5.

Relationship between patients' clinical responses and the chemosensitivity of the corresponding xenografts

Tumor codeCompoundPhase of therapyClinical responseResponse of the xenograftConcordance
HBC-12DocetaxelNeoadjuvantProgressionNo responseYes
HBC-1DocetaxelFirst linePartial responseResponseYes
HBC-3Docetaxel/5FUFirst lineStable diseaseLow responseYes
HBC-5DocetaxelFirst lineProgressionResponseNo
HBC-9DocetaxelFirst lineProgressionResponseNo
HBC-15DocetaxelFirst lineProgressionNo responseYes
HBC-5TrastuzumabSecond lineProgressionNo responseYes